Pharmaceutical companies created COVID-19
Disease is a lucrative business for pharmaceutical companies. During the SARS epidemic in the early 2000s, upwards of a $100 billion was spent on combative drugs. COVID-19 is a financial opportunity.
conspiracy
economics
misleading
pharmaceuticals
politics
<
(1 of 3)
Next argument >
Context
(ALERT: Visit the WHO for accurate information about the coronavirus pandemic)[1]
The Argument
Pharmaceutical companies make huge amounts of money from pandemics. Even if a vaccine is produced, in countries like America companies will profit hugely off of millions of people paying for it.[2] Author Gerald Posnet stated that “pharmaceutical companies view COVID-19 as a once-in-a-lifetime business opportunity.”[3]
Counter arguments
"Scientists from multiple countries have published and analysed genomes of the causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),1 and they overwhelmingly conclude that this COVID-19 originated in wildlife, as have so many other emerging pathogens."[4]
Premises
Rejecting the premises
References
- https://www.who.int/emergencies/diseases/novel-coronavirus-2019
- https://www.nytimes.com/2020/03/18/opinion/coronavirus-vaccine-cost.html
- https://theintercept.com/2020/03/13/big-pharma-drug-pricing-coronavirus-profits/
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30418-9/fulltext